Research Topics
| A Richard GreenSummaryAffiliation: AstraZeneca R and D Publications
| Collaborators
|
Detail Information
Publications
The metabolism of clomethiazole in gerbils and the neuroprotective and sedative activity of the metabolitesA R Green
AstraZeneca R and D Charnwood, Bakewell Road, Loughborough LE11 5RH, UK
Br J Pharmacol 129:95-100. 2000..These data suggest that the neuroprotective action of clomethiazole results from an action of the parent compound and that NLA-715 contributes to the sedative activity of the drug. British Journal of Pharmacology (2000) 129, 95 - 100..
Animal models of stroke: do they have value for discovering neuroprotective agents?A Richard Green
AstraZeneca R and D Charnwood, Loughborough LE11 5RH, UK
Trends Pharmacol Sci 24:402-8. 2003..We review earlier guidelines on the information that is necessary from preclinical studies before a compound enters clinical trials, and propose modifications to these guidelines...
Nitrones as neuroprotective agents in cerebral ischemia, with particular reference to NXY-059A Richard Green
AstraZeneca R and D Charnwood, Bakewell Road, Loughborough, Leics LE11 5RH, UK
Pharmacol Ther 100:195-214. 2003..NXY-059 may thus be the first compound to be examined in stroke patients using drug exposure and time to treatment that have been shown to be effective in animal models of stroke...
Neuropharmacology of 5-hydroxytryptamineA Richard Green
Global Discovery CNS and Pain Control, AstraZeneca R and D Charnwood, Bakewell Road, Loughborough LE11 5RH
Br J Pharmacol 147:S145-52. 2006..A major challenge now is to utilise this knowledge to develop receptor-specific drugs and use the information gained to better treat central nervous system disorders...
Effect of ambient temperature and a prior neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA) on the hyperthermic response of rats to a single or repeated ('binge' ingestion) low dose of MDMAA Richard Green
Neuropharmacology Research Group, School of Pharmacy, De Montfort University, The Gateway, Leicester, LE1 9BH, UK
Psychopharmacology (Berl) 173:264-9. 2004..3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) administration to rats produces acute hyperthermia and long-term neurotoxic damage to 5-hydroxytryptamine (serotonin, 5-HT) neurones...
MDMA: fact and fallacy, and the need to increase knowledge in both the scientific and popular pressA Richard Green
Neuropharmacology Research Group, School of Pharmacy, De Montfort University, The Gateway, Leicester, LE1 9BH, UK
Psychopharmacology (Berl) 173:231-3. 2004
Studies on the effect of MDMA ('ecstasy') on the body temperature of rats housed at different ambient room temperaturesA Richard Green
Neuropharmacology Research Group, Leicester School of Pharmacy, De Montfort University, Leicester LE1 9BH
Br J Pharmacol 146:306-12. 2005....
Free radical trapping as a therapeutic approach to neuroprotection in stroke: experimental and clinical studies with NXY-059 and free radical scavengersA Richard Green
Global Discovery CNS and Pain Control, AstraZeneca R and D Charnwood, Bakewell Road, Loughborough LE11 5RH, UK
Curr Drug Targets CNS Neurol Disord 4:109-18. 2005....
A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic responseA Richard Green
Neuropharmacology Research Group, School of Pharmacy, De Montfort University, The Gateway, Leicester LE1 9BH, UK
Eur J Pharmacol 500:3-13. 2004..These results suggest that any MDMA-induced hyperthermic response will be enhanced in hot, crowded dance club conditions and that ingesting the drug in such conditions increases the possibility of subsequent cerebral neurotoxic effect...
The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy")A Richard Green
AstraZeneca R and D Charnwood, Loughborough, LE11 5RH, UK
Pharmacol Rev 55:463-508. 2003..However, such evidence is complicated by the lack of knowledge of doses ingested and the fact that many subjects studied are or have been poly-drug users...
A brief history of British Pharmacological Society meetingsA Richard Green
Global Discovery CNS and Pain Control, AstraZeneca R and D Charnwood, Loughborough LE11 5RH, UK
Trends Pharmacol Sci 27:177-81. 2006..However, evidence suggests that the Society will continue to move strongly and confidently towards its 100th birthday...
Protecting the brain: the search for a clinically effective neuroprotective drug for strokeA Richard Green
AstraZeneca R and D Charnwood, Bakewell Road, Loughborough, UK
Crit Rev Neurobiol 16:91-7. 2004....
Therapeutic strategies for the treatment of strokeA Richard Green
Global Discovery CNS and Pain Control, AstraZeneca R and D Charnwood, Bakewell Road, Loughborough, LE11 5RH, UK
Drug Discov Today 11:681-93. 2006..There are a variety of new neuroprotective compounds in the early stages of investigation and some could prove clinically effective, provided appropriate preclinical development guidelines are observed...
GABA potentiation: a logical pharmacological approach for the treatment of acute ischaemic strokeA R Green
AstraZeneca R and D Charnwood, Bakewell Rd, LE11 5RH, Loughborough, UK
Neuropharmacology 39:1483-94. 2000..The diversity of GABA(A) receptor subtypes and the in vivo efficacy of certain GABA(A) receptor ligands in animal models of stroke suggests that GABAmimetic drugs are an undervalued approach to stroke therapy...
Why do neuroprotective drugs that are so promising in animals fail in the clinic? An industry perspectiveA Richard Green
AstraZeneca R and D Charnwood, Loughborough, England
Clin Exp Pharmacol Physiol 29:1030-4. 2002..5. It is concluded that we will only achieve the goal of producing a clinically effective neuroprotective agent if the guidelines have been met by the novel compound under investigation...
The interaction of AR-A008055 and its enantiomers with the GABA(A) receptor complex and their sedative, muscle relaxant and anticonvulsant activityA R Green
AstraZeneca R and D Charnwood, Loughborough LE11 5RH, UK
Neuropharmacology 41:167-74. 2001..The current data suggest that the proposed GABA uptake inhibitory property of (R)-(+)-AR-A008055 fails to produce significant sedative, myorelaxant or anticonvulsant activity...
The role of 5-HT in the impairment of thermoregulation observed in rats administered MDMA ('ecstasy') when housed at high ambient temperatureKathryn S Saadat
Neuropharmacology Research Group, Leicester School of Pharmacy, De Montfort University, The Gateway Leicester, LE1 9BH, UK
Psychopharmacology (Berl) 179:884-90. 2005..These data could have implications for recreational users of MDMA, who may have damaged serotoninergic neurons because of prior heavy or frequent use of the drug, when taking further doses of MDMA in hot environments such as dance clubs...
The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to ratsAnnis O Mechan
Pharmacology Research Group, School of Pharmacy, De Montfort University, The Gateway, Leicester LE1 9RH
Br J Pharmacol 135:170-80. 2002..This has implications for the clinical treatment of MDMA-induced hyperthermia...
The acute and long-term neurotoxic effects of MDMA on marble burying behaviour in miceKathryn S Saadat
Neuropharmacology Research Group, Leicester School of Pharmacy, De Montfort University, UK
J Psychopharmacol 20:264-71. 2006..Long-term loss of cerebral 5-HT content also produced a similar effect. Since this change was observed only after 28 days, it is probably due to an adaptive response in the brain...
Brain penetration of the novel free radical trapping neuroprotectant NXY-059 in rats subjected to permanent focal ischemiaA Richard Green
AstraZeneca R and D Charnwood, Bakewell Rd, Loughborough LE11 5RH, Sweden
Brain Res 1072:224-6. 2006..These data demonstrate that NXY-059 does penetrate brain tissue in control animals and ischemic tissue of animals subjected to pMCAO...
High-dose MDMA does not result in long-term changes in impulsivity in the ratKathryn S Saadat
Neuropharmacology Research Group, School of Pharmacy, De Monfort University, The Gateway, Leicester, LE1 9BH, UK
Psychopharmacology (Berl) 188:75-83. 2006..MDMA reduced cortical 5-HT content (MDMA 363 +/- 14 ng/g and control 440 +/- 10 ng/g tissue). CONCLUSION: These results suggest that impulsivity may not be directly altered by MDMA despite serotonergic neurotoxicity...
Effect of 5-HT depletion by MDMA on hyperthermia and Arc mRNA induction in rat brainThomas J R Beveridge
School of Pharmacy, De Montfort University, Leicester, LE1 9BH, UK
Psychopharmacology (Berl) 173:346-52. 2004..However, following a neurotoxic dose of MDMA, basal expression of Arc is increased, particularly in cortex and CA1, suggesting that mechanisms underlying synaptic plasticity might also be modified...
Glutamate receptor-mediated inhibition of L-glutamate efflux from cerebral cortex in vitroAtticus H Hainsworth
Pharmacology Research Group, Leicester School of Pharmacy, De Montfort University, Leicester, LE1 9BH, UK
Brain Res 1114:36-40. 2006..These data support a modulatory effect of glutamate receptors on L-glutamate efflux...
Investigating the free radical trapping ability of NXY-059, S-PBN and PBNHelen E Williams
AstraZeneca, Pharmaceutical and Analytical R and D, Macclesfield, Cheshire, UK
Free Radic Res 41:1047-52. 2007..The results obtained showed that NXY-059 trapped a greater number of hydroxyl and methanol radicals than the other two nitrones, under the conditions studied...
Optimising in vivo pharmacology studies--Practical PKPD considerationsJohan Gabrielsson
PKPD section, Drug discovery DMPK and BAC, CVGI, AstraZeneca R and D Molndal, S 43183 Mölndal, Sweden
J Pharmacol Toxicol Methods 61:146-56. 2010....
Electrophysiological actions of gamma-aminobutyric acid and clomethiazole on recombinant GABA(A) receptorsRachael M Nelson
Pharmacology Research Group, School of Pharmacy, De Montfort University, LE1 9BH, Leicester, UK
Eur J Pharmacol 452:255-62. 2002..8-fold increase in maximal current. Both direct activation and gamma-aminobutyric acid potentiation are likely to contribute to the in vivo profile of clomethiazole...
Nitrone-related therapeutics: potential of NXY-059 for the treatment of acute ischaemic strokeKirk R Maples
Anacor Pharmaceuticals Inc, Palo Alto, California, USA
CNS Drugs 18:1071-84. 2004..Further experiments are required to fully elucidate the mechanism of action of these very effective neuroprotective agents...
Studies, using in vivo microdialysis, on the effect of the dopamine uptake inhibitor GBR 12909 on 3,4-methylenedioxymethamphetamine ('ecstasy')-induced dopamine release and free radical formation in the mouse striatumJorge Camarero
Departamento de Farmacologia, Facultad de Medicina, Universidad Complutense, Madrid, Spain
J Neurochem 81:961-72. 2002..The data also indicate that the free radical formation is probably not associated with the MDMA-induced dopamine release and that MDMA does not induce dopamine release via an action at the dopamine transporter...
The nitrone disodium 2,4-sulphophenyl-N-tert-butylnitrone is without cytoprotective effect on sodium nitroprusside-induced cell death in N1E-115 neuroblastoma cells in vitroAtticus H Hainsworth
Division of Cardiac and Vascular Sciences, Department of Clinical Neurosciences, St George s University of London, London, UK
J Cereb Blood Flow Metab 28:24-8. 2008..These results support recent data suggesting that in vivo NXY-059 probably acts at the neurovascular unit rather than at an intracellular site as a neuroprotective agent...
On the anxiogenic and anxiolytic nature of long-term cerebral 5-HT depletion following MDMAA Richard Green
Psychopharmacology (Berl) 162:448-50. 2002
The nNOS inhibitor, AR-R17477AR, prevents the loss of NF68 immunoreactivity induced by methamphetamine in the mouse striatumVeronica Sanchez
Departamento de Farmacologia and Facultad de Medicina Instituto de Bioquimica CSIC UCM, Facultad de Farmacia, Universidad Complutense, Madrid, Spain
J Neurochem 85:515-24. 2003..These data indicate that both the reduction of NF68 immunoreactivity and the loss of dopamine concentration are due to an oxidative stress process mediated by reactive nitrogen species, and are not due to changes in body temperature...
Comparison of the neuroprotective effect of clomethiazole, AR-R15896AR and NXY-059 in a primate model of stroke using histological and behavioural measuresJonathan W B Marshall
MRC Comparative Cognition Team, Department of Experimental Psychology, University of Cambridge, Downing Street, Cambridge CB2 3EB, UK
Brain Res 972:119-26. 2003..The overview of the behavioural effects and these new histological findings suggest that NXY-059 was by far the most effective neuroprotective agent of the three examined...
Functional and histological evidence for the protective effect of NXY-059 in a primate model of stroke when given 4 hours after occlusionJonathan W B Marshall
Medical Research Council Comparative Cognition Team, Department of Experimental Psychology, University of Cambridge, UK
Stroke 34:2228-33. 2003..This study examined the efficacy of this drug when administered 4 hours after onset, a more clinically relevant time point...
Hyperthermic and neurotoxic effect of 3,4-methylenedioxymethamphetamine (MDMA) in guinea pigsKathryn S Saadat
Psychopharmacology (Berl) 173:452-3. 2004
3,4-Methylenedioxymethamphetamine increases interleukin-1beta levels and activates microglia in rat brain: studies on the relationship with acute hyperthermia and 5-HT depletionLaura Orio
Departamento de Farmacologia, Facultad de Medicina, Universidad Complutense, Madrid 28040, Spain
J Neurochem 89:1445-53. 2004..Contrary to IL-1beta levels, microglial activation is not significantly modified when hyperthermia is prevented, suggesting that it might be a process not dependent on the hyperthermic response induced by MDMA...
Elevation of ambient room temperature has differential effects on MDMA-induced 5-HT and dopamine release in striatum and nucleus accumbens of ratsIsabel Escobedo
Departamento de Farmacologia, Facultad de Medicina, Universidad Complutense, Madrid, Spain
Neuropsychopharmacology 30:1312-23. 2005....
Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neuronesVeronica Sanchez
Departamento de Farmacologia, Facultad de Medicina, Universidad Complutense, Madrid, Spain
J Psychopharmacol 18:412-6. 2004....
On the protection against methamphetamine-induced neurotoxicity by benzamide, a PARP inhibitorVeronica Sanchez
Departamento de Farmacologia, Facultad de Medicina, Universidad Complutense, 28040 Madrid, Spain
Psychopharmacology (Berl) 165:317-9. 2003
Acute and long-term effects of MDMA on cerebral dopamine biochemistry and functionM Isabel Colado
Departamento de Farmacologia, Facultad de Medicina, Universidad Complutense, 28040 Madrid, Spain
Psychopharmacology (Berl) 173:249-63. 2004..We suggest more focus be made on the actions of MDMA on dopamine neurochemistry and function to provide a better understanding of the acute and long-term consequences of using this popular recreational drug...
